Literature DB >> 25948539

Anthracycline cardiotoxicity: a new paradigm for an old classic.

John D Groarke1, Anju Nohria2.   

Abstract

Entities:  

Keywords:  Editorials; anthracyclines; cardiotoxicity

Mesh:

Substances:

Year:  2015        PMID: 25948539     DOI: 10.1161/CIRCULATIONAHA.115.016704

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  22 in total

1.  First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia.

Authors:  Zarir Ahmed; Elizabeth Davaro; Jacqueline Batanian; Nilesh Verma
Journal:  BMJ Case Rep       Date:  2019-05-16

2.  Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients: A Systematic Review.

Authors:  Kelly Liesse; Jamie Harris; Megan Chan; Mary L Schmidt; Bill Chiu
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289

Review 3.  Current views on anthracycline cardiotoxicity.

Authors:  Donato Mele; Marianna Nardozza; Paolo Spallarossa; Antonio Frassoldati; Carlo G Tocchetti; Christian Cadeddu; Rosalinda Madonna; Michele Malagù; Roberto Ferrari; Giuseppe Mercuro
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

4.  Two-Dimensional Speckle Tracking Echocardiography-Derived Strain Measurements in Survivors of Childhood Cancer on Angiotensin Converting Enzyme Inhibition or Receptor Blockade.

Authors:  Jamie K Harrington; Marc E Richmond; Arielle W Fein; Serge Kobsa; Prakash Satwani; Amee Shah
Journal:  Pediatr Cardiol       Date:  2018-05-22       Impact factor: 1.655

Review 5.  Cardiovascular Risk in Survivors of Cancer.

Authors:  Henry Chen Zheng; Laura Onderko; Sanjeev A Francis
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

6.  Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer.

Authors:  Hyun Ju Yoon; Kye Hun Kim; Jong Yoon Kim; Hyuk Jin Park; Jae Yeong Cho; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

Review 7.  Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.

Authors:  Hyungseop Kim; Woo-Baek Chung; Kyoung Im Cho; Bong-Joon Kim; Jeong-Sook Seo; Seong-Mi Park; Hak Jin Kim; Ju-Hee Lee; Eun Kyoung Kim; Ho-Joong Youn
Journal:  J Cardiovasc Ultrasound       Date:  2018-03-28

8.  Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice.

Authors:  Xiaoping Hu; Baijun Li; Luocheng Li; Bowen Li; Jinlong Luo; Bin Shen
Journal:  Oxid Med Cell Longev       Date:  2020-05-15       Impact factor: 6.543

9.  Inhibition of miR-25 attenuates doxorubicin-induced apoptosis, reactive oxygen species production and DNA damage by targeting PTEN.

Authors:  Zhiqiang Li; Hongqiang Li; Baoxin Liu; Jiachen Luo; Xiaoming Qin; Mengmeng Gong; Beibei Shi; Yidong Wei
Journal:  Int J Med Sci       Date:  2020-06-05       Impact factor: 3.738

10.  EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: a feasibility study protocol.

Authors:  Melanie R Keats; Scott A Grandy; Nicholas Giacomantonio; David MacDonald; Miroslaw Rajda; Tallal Younis
Journal:  Pilot Feasibility Stud       Date:  2016-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.